The new 1 million-plus square foot facility will begin manufacturing the injectable pens in 2025. It’s part of an ongoing strategy to grow manufacturing to meet unprecedented demand. Lilly and ...

The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...